⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Tata India Pharma & Healthcare Fund - Regular Plan - IDCW Payout | TRUSTMF Small Cap Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Tata MF | Trust MF |
| Category | Equity - Sectoral Fund - Pharma & Health Care | Equity - Small cap Fund |
| NAV | ₹31.57 (16 Sep 2026) | ₹13.65 (16 Sep 2026) |
| Rating | ★★★★ | ★★★ |
| Benchmark | BSE Health Care - TRI | Nifty Smallcap 250 - TRI |
| Fund Manager | Rajat Srivastava | Mihir Vora |
| Inception | 28 Dec 2015 | 04 Nov 2024 |
| Returns | ||
| 1Y | 6.45% | 27.33% |
| 3Y | 17.16% | — |
| 5Y | 12.38% | — |
| Since Inception | 11.74% | 18.15% |
| Risk | ||
| 14.61 | 22.45 | |
| 0.73 | 0.94 | |
| 1.02 | 0.29 | |
| 10.84 | 11.38 | |
| 2.20 | 0.53 | |
| -9.97% | -15.49% | |
| Costs | ||
| Expense Ratio | 2.32% | 1.56% |
| Exit Load | 0.25% on or before 30D | 1% on or before 180D, Nil after 180D |
| Min SIP | ₹100 | ₹1,000 |
| Min Lumpsum | ₹5,000 | ₹1,000 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Portfolio holdings aren't disclosed for one or both funds, so overlap can't be computed.
Category context: Equity vs Equity. Open the full Screener →